The Global Constipation Treatment Market Is Witnessing High Growth Owing To the Increasing Incidence of the Geriatric Population in the World

Constipation Treatment Market
Constipation Treatment Market

Constipation Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028.

Market Overview:

Constipation is a common condition that occurs when the bowels do not move enough stool through the colon. It can be painful, and distressing. It can also affect the quality of life. Symptoms of constipation include having a hard, dry stool that is difficult to pass. It may be infrequent (less than three times a week) or occur when patients strain to have a bowel movement. There are several different causes of constipation, including lack of fiber in the diet, aging, certain medications, and specific diseases such as irritable bowel syndrome or pregnancy. Treatments for constipation are usually based on lifestyle changes.

Competitive Landscape:

Major players operating in the global global constipation treatment for market include Takeda Pharmaceutical Company Limited, Shionogi, Sanofi, Renexxion, Prestige Brands, Mallinckrodt Plc, Janssen Pharmaceutical, Ironwood Pharmaceuticals, Daewoong, Cosmo Pharma, Bayer AG, Bausch Health Companies Inc., AstraZeneca, Albireo Pharma, Inc., AbbVie`s Inc., and Abbott.

Key Market Drivers:

The increasing incidence of the geriatric population in the world is expected to augment the growth of the global Constipation Treatment Market.

For instance, according to the World Health Organization, the proportion of the worldwide population aged over 60 will increase to 22% by 2050. Some people find that stool softeners such as docusate sodium or docusate calcium can help soften the stools. The healthcare provider can prescribe these medications and instruct how to use them. If individuals have chronic constipation, the doctor can recommend a series of enemas.

These are used to soften the stool and can be bought at a pharmacy or online. If individuals have chronic constipation caused by anorectal dysfunction, a biofeedback session can help retrain the pelvic muscles to control how much stool they produce. A therapist will guide patients through exercises to alternately relax and tighten the pelvic muscles. Moreover, high advancements in the pharmaceutical sector are estimated to enhance the growth of the global constipation treatment for the market.

Throughout the projected period, the market is anticipated to rise due to the rising number of drugs being approved for the Neuroendocrine Tumor Treatment Market.

Covid-19 Impact Analysis:

During the COVID-19 pandemic, there have been several developments in the global Constipation Treatment Market. For instance, in February 2021, Cosmo Pharmaceuticals NV and RedHill Biopharma Ltd. signed an agreement in order to develop RHB-204 and Movantik.

Key Takeaways:

· North America is expected to dominate the growth of the global constipation treatment for the market, owing to the high rate of developments by major companies in the region. For instance, in April 2022, Ardelyx, Inc. received approval from the United States Food and Drug Administration (USFDA) for IBSRELA, which is an NHE3 inhibitor used for treating constipation in adults.

· The Asia Pacific is estimated to witness high growth in the global Constipation Treatment Market, owing to the increasing product launches by key players in the region. For instance, in May 2022, Mochida Pharmaceutical and EA Pharma introduced a chronic constipation treatment in Japan, called MOVICOL HD.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more